Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 26 05 2021
revised: 08 07 2021
accepted: 19 07 2021
pubmed: 30 7 2021
medline: 18 9 2021
entrez: 29 7 2021
Statut: ppublish

Résumé

Several central and peripheral nervous system complications associated with the severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection have been recently described. An effective mass vaccination program is necessary to effectively reduce infection spread and, consequently, limit long-term sequelae, including those affecting the nervous system. Nevertheless, as more patients gain access to coronavirus disease 2019 (COVID-19) vaccines, it is important to report potential adverse events. Herein, we report a patient with previous history of post-infectious rhombencephalitis who developed an acute disseminated encephalomyelitis (ADEM) two weeks after being vaccinated for COVID-19.

Identifiants

pubmed: 34325334
pii: S0303-8467(21)00368-1
doi: 10.1016/j.clineuro.2021.106839
pmc: PMC8294707
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
BNT162 Vaccine N38TVC63NU

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106839

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Auto Immun Highlights. 2020 Jan 22;11(1):2
pubmed: 32127039
Ann Neurol. 2021 May;89(5):856-857
pubmed: 33710649
Dev Med Child Neurol. 2018 Nov;60(11):1123-1131
pubmed: 29744874
J Infect Dis. 2020 Mar 28;221(8):1295-1303
pubmed: 31268141
Pharmacogenomics J. 2016 Feb;16(1):96-101
pubmed: 25823688
Neurologist. 2018 Nov;23(6):198-203
pubmed: 30379745
Neurol Sci. 2020 Dec;41(12):3391-3394
pubmed: 33006723
Mult Scler. 2013 Sep;19(10):1261-7
pubmed: 23572237
Acta Neurol Belg. 2022 Jun;122(3):793-795
pubmed: 33527327

Auteurs

Alberto Vogrig (A)

Clinical Neurology, Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy. Electronic address: alberto.vogrig@asufc.sanita.fvg.it.

Francesco Janes (F)

Clinical Neurology, Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy.

Gian Luigi Gigli (GL)

Clinical Neurology, Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy; Neurology Unit, Department of Medicine, University of Udine, Udine, Italy.

Francesco Curcio (F)

Clinical Pathology, Department of Laboratory Medicine, Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy.

Ilaria Del Negro (ID)

Neurology Unit, Department of Medicine, University of Udine, Udine, Italy.

Serena D'Agostini (S)

Neuroradiology, Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy.

Martina Fabris (M)

Clinical Pathology, Department of Laboratory Medicine, Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy.

Mariarosaria Valente (M)

Clinical Neurology, Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy; Neurology Unit, Department of Medicine, University of Udine, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH